Fund Relaunches Trasylol Class Action Against Bayer
By Leigh Kamping-Carder · September 11, 2009, 3:36 PM EDT
A Tennessee benefits fund has taken another shot at filing a proposed class action against Bayer Corp. over alleged fraud in the marketing of the lucrative blood-clotting drug Trasylol, just weeks...
To view the full article, register now.